Analyst Coverage

Analyst Coverage

The following research analysts cover Destiny Pharma.

Mark Brewer, finnCap +44(0)20 7220 0500
Andy Smith, Equity Development +44(0)20 7065 2690

 

Please click on links below to access coverage published:

finnCap finnCap

Analyst research from finnCap can be obtained by registering on the link above

14 April 2021 – Destiny Pharma – FY 2020: a year to remember – not just for COVID-19

Equity Development Equity Development

02 August 2021 – XF-73 data maturing, like a fine wine

02 July 2021 – A glaring differential in validation

Destiny Pharma - Proactive Proactive Investors

For further commentary and interviews, please visit the Destiny Pharma page at Proactive Investors on the link above